2Gleadhill IC, Schwartz AR, Schubert N, et al. Upper airway collapsibility in snorers andin patients with obstructive hypopnea and apnea. Am Rev Respir Dis, 1991,143(6) : 1300- 1303.
3King ED, O'Donnell CP, Smith PL, et al. A model of obstructive sleep apnea in normal humans: Role of the upper airway. Am J Respir Crit Care Med ,2000,161 (6) : 1979 -1984.
4Farré R, Peslin R, Montserrat JM, et al.Flow-dependent positive airway pressure to maintain airway patency in sleep apnea-hy-popnea syndrome. Am J Respir Crit Care Med,1998,157(6 Pt 1):1855 - 1863.
5Lorino AM, Lofaso F, Duizabo D, et al. Respiratory resistive impedance as an index of airway obstruction during nasal continuous positive airway pressure titration. Am J Respir Crit Care Med, 1998,158 (5 Pt 1 ) : 1465 -1470.
6Gold AR, Schwartz AR. The pharyngeal critical pressure: The whys and hows of using nasal continuous positive airway pressure diagnostically. Chest, 1996, 110 (4): 1077 -1088.
7Resta O, Guido P, Picca V, et al. The role of the expiratory phase in obstructive sleep apnoea. Respir Med, 1999, 93(3):190- 195.
8Mehta S, Hill NS. Noninvasive ventilation.Am J Respir Crit Care Med, 2001,163(2):540 - 577.
9CordingJey JJ, Keogh BF. The pulmonary physician in critical care 8: venfilatory management of ALI/ARDS. Thorax, 2002, 57(7) :729 - 734.
10Walmrath D, Grimminger F, Pappert D, et al. Bronchoscopic administration of bovine natural suffactant in ARDS and septic shock:impact on gas exchange and haemodynamics.Eur Respir J,2002,19(5) :805 - 810.
